| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 2.12e-06 | 82 | 144 | 7 | GO:1990756 | |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | 5.70e-06 | 95 | 144 | 7 | GO:0140767 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 4.74e-05 | 55 | 144 | 5 | GO:0042974 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.42e-04 | 37 | 144 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.15e-04 | 118 | 144 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 2.77e-04 | 18 | 144 | 3 | GO:0004016 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.77e-04 | 18 | 144 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | cyclase activity | 6.65e-04 | 24 | 144 | 3 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 7.52e-04 | 25 | 144 | 3 | GO:0016849 | |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | CENPE TRRAP CDC14B CDC45 FANCD2 RINT1 MDC1 ETAA1 TTI1 ATM PLK3 | 3.48e-07 | 217 | 143 | 11 | GO:0000075 |
| GeneOntologyBiologicalProcess | DNA integrity checkpoint signaling | 7.83e-07 | 145 | 143 | 9 | GO:0031570 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | ATF5 CENPE TRRAP CDC14B CDC45 FANCD2 RINT1 CHTF18 MDC1 ETAA1 TTI1 ATM PLK3 | 1.48e-06 | 362 | 143 | 13 | GO:0010948 |
| GeneOntologyBiologicalProcess | cell cycle phase transition | ATF5 CENPE AMBRA1 TRRAP CDC14B CDC45 FANCD2 CCNH RINT1 PPP6C MDC1 EIF4E ETAA1 TTI1 ATM PLCG2 PLK3 | 1.70e-06 | 627 | 143 | 17 | GO:0044770 |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle phase transition | ATF5 CENPE TRRAP CDC14B CDC45 FANCD2 RINT1 MDC1 ETAA1 TTI1 ATM PLK3 | 1.82e-06 | 311 | 143 | 12 | GO:1901988 |
| GeneOntologyBiologicalProcess | mitotic cell cycle checkpoint signaling | 2.08e-06 | 163 | 143 | 9 | GO:0007093 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | ATF5 CENPE AMBRA1 TRRAP CDC14B CDC45 FANCD2 CCNH RINT1 MDC1 ETAA1 TTI1 ATM PLCG2 PLK3 | 3.11e-06 | 516 | 143 | 15 | GO:1901987 |
| GeneOntologyBiologicalProcess | DNA damage checkpoint signaling | 4.89e-06 | 136 | 143 | 8 | GO:0000077 | |
| GeneOntologyBiologicalProcess | germ cell development | ADCY10 DNHD1 PRAMEF20 PRAMEF15 DRC1 PRAMEF4 DNAH1 IFT88 EHHADH CHTF18 PAEP ATM CFAP61 PRAMEF11 | 6.82e-06 | 482 | 143 | 14 | GO:0007281 |
| GeneOntologyBiologicalProcess | microtubule-based movement | ADCY10 DNHD1 DNAH10 CENPE DRC1 SPG11 ADCY3 DNAH1 DNAJB13 DNAAF5 IFT88 SYNE2 CFAP61 KPNB1 | 8.80e-06 | 493 | 143 | 14 | GO:0007018 |
| GeneOntologyBiologicalProcess | signal transduction in response to DNA damage | 1.10e-05 | 200 | 143 | 9 | GO:0042770 | |
| GeneOntologyBiologicalProcess | sexual reproduction | ADCY10 DNHD1 ERCC4 SETX CENPE CECR2 PRAMEF20 PRAMEF15 INSR DRC1 PRAMEF4 ADCY3 CCIN DNAH1 FANCD2 DNAJB13 IFT88 EHHADH CHTF18 PAEP ATM CFAP61 HSF2 PRAMEF11 | 1.15e-05 | 1312 | 143 | 24 | GO:0019953 |
| GeneOntologyBiologicalProcess | microtubule-based process | ADCY10 DNHD1 ATF5 CDC42BPA DNAH10 CENPE DRC1 SPG11 CDC14B ADCY3 TUBB2A DNAH1 DNAJB13 DNAAF5 IFT88 EHHADH SYNE2 CFAP61 PLK3 TBCEL KPNB1 | 1.31e-05 | 1058 | 143 | 21 | GO:0007017 |
| GeneOntologyBiologicalProcess | cilium movement | ADCY10 DNHD1 DNAH10 DRC1 ADCY3 DNAH1 DNAJB13 DNAAF5 IFT88 CFAP61 | 1.45e-05 | 261 | 143 | 10 | GO:0003341 |
| GeneOntologyBiologicalProcess | blastocyst formation | 1.70e-05 | 78 | 143 | 6 | GO:0001825 | |
| GeneOntologyBiologicalProcess | cellular process involved in reproduction in multicellular organism | ADCY10 DNHD1 PRAMEF20 PRAMEF15 DRC1 PRAMEF4 DNAH1 IFT88 EHHADH CHTF18 PAEP ATM CFAP61 PRAMEF11 | 1.85e-05 | 527 | 143 | 14 | GO:0022412 |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle | ATF5 CENPE TRRAP CDC14B CDC45 FANCD2 RINT1 CHTF18 MDC1 ETAA1 TTI1 ATM PLK3 | 2.15e-05 | 464 | 143 | 13 | GO:0045786 |
| GeneOntologyBiologicalProcess | mitotic cell cycle | NRDE2 CENPE INSR AMBRA1 TRRAP CDC14B TUBB2A CDC45 FANCD2 CCNH RINT1 PPP6C EHHADH MDC1 EIF4E ETAA1 ATM NIPBL PLK3 KPNB1 | 2.35e-05 | 1014 | 143 | 20 | GO:0000278 |
| GeneOntologyBiologicalProcess | negative regulation of telomere capping | 2.66e-05 | 9 | 143 | 3 | GO:1904354 | |
| GeneOntologyBiologicalProcess | mitotic DNA damage checkpoint signaling | 4.11e-05 | 91 | 143 | 6 | GO:0044773 | |
| GeneOntologyBiologicalProcess | sperm flagellum assembly | 4.29e-05 | 56 | 143 | 5 | GO:0120316 | |
| GeneOntologyBiologicalProcess | gamete generation | ADCY10 DNHD1 SETX CENPE PRAMEF20 PRAMEF15 DRC1 PRAMEF4 CCIN DNAH1 FANCD2 IFT88 EHHADH CHTF18 PAEP ATM CFAP61 HSF2 PRAMEF11 | 4.96e-05 | 982 | 143 | 19 | GO:0007276 |
| GeneOntologyBiologicalProcess | cAMP biosynthetic process | 5.17e-05 | 11 | 143 | 3 | GO:0006171 | |
| GeneOntologyBiologicalProcess | mitotic DNA integrity checkpoint signaling | 5.23e-05 | 95 | 143 | 6 | GO:0044774 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | ATF5 CENPE INSR AMBRA1 TRRAP CDC14B CDC45 FANCD2 CCNH RINT1 CHTF18 MDC1 ETAA1 TTI1 ATM PLCG2 PLK3 | 7.95e-05 | 845 | 143 | 17 | GO:0010564 |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | CENPE INSR AMBRA1 TRRAP CDC14B CDC45 FANCD2 CCNH RINT1 PPP6C MDC1 EIF4E ETAA1 ATM NIPBL PLK3 KPNB1 | 9.04e-05 | 854 | 143 | 17 | GO:1903047 |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 1.11e-04 | 210 | 143 | 8 | GO:0060294 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 1.30e-04 | 215 | 143 | 8 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 1.30e-04 | 215 | 143 | 8 | GO:0001539 | |
| GeneOntologyBiologicalProcess | cell cycle process | ERCC4 ATF5 CENPE CECR2 INSR AMBRA1 TRRAP CDC14B CDC45 FANCD2 CCNH RINT1 PPP6C CHTF18 MDC1 EIF4E ETAA1 TTI1 ATM PLCG2 NIPBL PLK3 KPNB1 | 1.45e-04 | 1441 | 143 | 23 | GO:0022402 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | ATF5 CDC42BPA CENPE DRC1 CDC14B TUBB2A DNAH1 DNAJB13 DNAAF5 IFT88 EHHADH SYNE2 PLK3 TBCEL KPNB1 | 1.47e-04 | 720 | 143 | 15 | GO:0000226 |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle | 1.59e-04 | 282 | 143 | 9 | GO:0045930 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle G2/M phase transition | 1.98e-04 | 77 | 143 | 5 | GO:1902750 | |
| GeneOntologyBiologicalProcess | blastocyst development | 2.56e-04 | 179 | 143 | 7 | GO:0001824 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | CENPE INSR AMBRA1 TRRAP CDC14B FANCD2 CCNH RINT1 MDC1 EIF4E ETAA1 ATM PLK3 | 2.58e-04 | 594 | 143 | 13 | GO:0007346 |
| GeneOntologyBiologicalProcess | mitotic chromosome movement towards spindle pole | 2.84e-04 | 4 | 143 | 2 | GO:0007079 | |
| GeneOntologyBiologicalProcess | flagellated sperm motility | 3.23e-04 | 186 | 143 | 7 | GO:0030317 | |
| GeneOntologyBiologicalProcess | motile cilium assembly | 3.69e-04 | 88 | 143 | 5 | GO:0044458 | |
| GeneOntologyBiologicalProcess | sperm motility | 4.03e-04 | 193 | 143 | 7 | GO:0097722 | |
| GeneOntologyBiologicalProcess | response to organophosphorus | 4.72e-04 | 142 | 143 | 6 | GO:0046683 | |
| GeneOntologyBiologicalProcess | spermatid development | 4.95e-04 | 262 | 143 | 8 | GO:0007286 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide biosynthetic process | 5.22e-04 | 23 | 143 | 3 | GO:0009190 | |
| GeneOntologyBiologicalProcess | histone mRNA metabolic process | 5.94e-04 | 24 | 143 | 3 | GO:0008334 | |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | ADCY10 DNHD1 SETX CENPE PRAMEF20 PRAMEF15 DRC1 PRAMEF4 CCIN DNAH1 FANCD2 IFT88 EHHADH CHTF18 PAEP ATM CFAP61 HSF2 PRAMEF11 | 6.02e-04 | 1194 | 143 | 19 | GO:0048609 |
| GeneOntologyBiologicalProcess | spermatid differentiation | 6.33e-04 | 272 | 143 | 8 | GO:0048515 | |
| GeneOntologyBiologicalProcess | oocyte development | 6.33e-04 | 99 | 143 | 5 | GO:0048599 | |
| GeneOntologyBiologicalProcess | response to magnesium ion | 6.71e-04 | 25 | 143 | 3 | GO:0032026 | |
| GeneOntologyBiologicalProcess | cAMP metabolic process | 6.71e-04 | 25 | 143 | 3 | GO:0046058 | |
| GeneOntologyBiologicalProcess | spermatid nucleus elongation | 7.03e-04 | 6 | 143 | 2 | GO:0007290 | |
| GeneOntologyBiologicalProcess | mitotic G2/M transition checkpoint | 7.50e-04 | 59 | 143 | 4 | GO:0044818 | |
| GeneOntologyBiologicalProcess | positive regulation of reactive oxygen species biosynthetic process | 7.55e-04 | 26 | 143 | 3 | GO:1903428 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 7.58e-04 | 103 | 143 | 5 | GO:0009994 | |
| GeneOntologyBiologicalProcess | regulation of telomere capping | 8.45e-04 | 27 | 143 | 3 | GO:1904353 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | ADCY10 DNHD1 SETX PRAMEF20 PRAMEF15 INSR DRC1 PRAMEF4 CCIN DNAH1 IFT88 EHHADH CHTF18 PAEP ATM CFAP61 HSF2 NIPBL PRAMEF11 | 9.02e-04 | 1235 | 143 | 19 | GO:0003006 |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 9.39e-04 | 108 | 143 | 5 | GO:0035019 | |
| GeneOntologyBiologicalProcess | axoneme assembly | 9.79e-04 | 109 | 143 | 5 | GO:0035082 | |
| GeneOntologyBiologicalProcess | chromosome movement towards spindle pole | 9.80e-04 | 7 | 143 | 2 | GO:0051305 | |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 1.07e-03 | 166 | 143 | 6 | GO:0014074 | |
| GeneOntologyBiologicalProcess | cilium assembly | DNHD1 DRC1 CDC14B DNAH1 DNAJB13 DNAAF5 IFT88 SYNE2 WDR90 CFAP61 | 1.08e-03 | 444 | 143 | 10 | GO:0060271 |
| GeneOntologyBiologicalProcess | DNA recombination | 1.09e-03 | 368 | 143 | 9 | GO:0006310 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | ATF5 CENPE FNTB INSR AMBRA1 TRRAP CDC14B CDC45 FANCD2 CCNH RINT1 CHTF18 MDC1 EIF4E ETAA1 TTI1 ATM PLCG2 PLK3 | 1.10e-03 | 1256 | 143 | 19 | GO:0051726 |
| GeneOntologyCellularComponent | axoneme | DNHD1 DNAH10 AMBRA1 DRC1 CFAP210 EFHB DNAH1 DNAJB13 EFHC2 IFT88 CFAP61 | 2.35e-07 | 207 | 146 | 11 | GO:0005930 |
| GeneOntologyCellularComponent | ciliary plasm | DNHD1 DNAH10 AMBRA1 DRC1 CFAP210 EFHB DNAH1 DNAJB13 EFHC2 IFT88 CFAP61 | 2.46e-07 | 208 | 146 | 11 | GO:0097014 |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 8.88e-07 | 47 | 146 | 6 | GO:0031462 | |
| GeneOntologyCellularComponent | cilium | ADCY10 DNHD1 DNAH10 PRAMEF20 PRAMEF15 CDH23 AMBRA1 DRC1 CFAP210 PRAMEF4 EFHB ADCY3 DNAH1 CDC45 DNAJB13 EFHC2 DNAAF5 IFT88 CFAP61 CNGA3 PRAMEF11 | 1.17e-06 | 898 | 146 | 21 | GO:0005929 |
| GeneOntologyCellularComponent | motile cilium | ADCY10 DNHD1 DNAH10 PRAMEF20 PRAMEF15 DRC1 PRAMEF4 DNAH1 DNAJB13 DNAAF5 IFT88 CFAP61 PRAMEF11 | 1.31e-06 | 355 | 146 | 13 | GO:0031514 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | DNHD1 DNAH10 AMBRA1 DRC1 GRIK2 CFAP210 EFHB DNAH1 DNAJB13 EFHC2 IFT88 CFAP61 | 2.41e-06 | 317 | 146 | 12 | GO:0032838 |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | CAND1 PRAMEF9 KBTBD6 PRAMEF20 PRAMEF15 AMBRA1 PRAMEF4 KBTBD7 PRAMEF27 PRAMEF11 | 2.48e-06 | 212 | 146 | 10 | GO:0031461 |
| GeneOntologyCellularComponent | cytoplasmic region | DNHD1 DNAH10 AMBRA1 DRC1 GRIK2 CFAP210 EFHB DNAH1 DNAJB13 EFHC2 IFT88 CFAP61 | 8.83e-06 | 360 | 146 | 12 | GO:0099568 |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.58e-05 | 25 | 146 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | inner dynein arm | 3.86e-05 | 10 | 146 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | ubiquitin ligase complex | CAND1 PRAMEF9 KBTBD6 PRAMEF20 PRAMEF15 AMBRA1 PRAMEF4 KBTBD7 PRAMEF27 PRAMEF11 | 1.88e-04 | 352 | 146 | 10 | GO:0000151 |
| GeneOntologyCellularComponent | dynein complex | 5.51e-04 | 54 | 146 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | UTP6 ERCC4 ATF5 MED29 GEMIN2 ICE2 CECR2 NCKIPSD HEATR1 TRRAP CDC45 CCNH SUPT6H CHTF18 RBMX2 SYNE2 CPSF2 NIPBL EPB41L2 SMG6 KPNB1 | 5.93e-04 | 1377 | 146 | 21 | GO:0140513 |
| GeneOntologyCellularComponent | acrosomal vesicle | 6.23e-04 | 206 | 146 | 7 | GO:0001669 | |
| GeneOntologyCellularComponent | cochlear hair cell ribbon synapse | 7.13e-04 | 6 | 146 | 2 | GO:0098683 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.44e-03 | 238 | 146 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | supramolecular fiber | KRT6A KRT6B ANK1 DNAH10 CENPE MYO6 MYO9B NCKIPSD CFAP210 EFHB TUBB2A RYR3 DNAH1 EFHC2 KRT24 KRT6C EHHADH SYNE2 | 1.48e-03 | 1179 | 146 | 18 | GO:0099512 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT6A KRT6B DNAH10 CENPE MYO6 MYO9B NCKIPSD CFAP210 EFHB TUBB2A DNAH1 EFHC2 KRT24 KRT6C EHHADH | 1.59e-03 | 899 | 146 | 15 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT6A KRT6B ANK1 DNAH10 CENPE MYO6 MYO9B NCKIPSD CFAP210 EFHB TUBB2A RYR3 DNAH1 EFHC2 KRT24 KRT6C EHHADH SYNE2 | 1.59e-03 | 1187 | 146 | 18 | GO:0099081 |
| HumanPheno | Absent sperm flagella | 5.01e-06 | 28 | 48 | 5 | HP:0032558 | |
| HumanPheno | Irregularly shaped sperm tail | 8.78e-06 | 15 | 48 | 4 | HP:0033393 | |
| HumanPheno | Coiled sperm flagella | 9.99e-06 | 32 | 48 | 5 | HP:0032560 | |
| HumanPheno | Short sperm flagella | 1.17e-05 | 33 | 48 | 5 | HP:0032559 | |
| HumanPheno | Reduced progressive sperm motility | 1.93e-05 | 18 | 48 | 4 | HP:0034011 | |
| HumanPheno | Reduced sperm motility | 3.89e-05 | 69 | 48 | 6 | HP:0012207 | |
| HumanPheno | Abnormal sperm tail morphology | 4.42e-05 | 43 | 48 | 5 | HP:0012868 | |
| HumanPheno | Decreased fertility in males | DNHD1 ERCC4 DNAH10 CDH23 DRC1 DNAH1 FANCD2 DNAJB13 DNAAF5 CFAP61 | 5.20e-05 | 236 | 48 | 10 | HP:0012041 |
| HumanPheno | Abnormal sperm motility | 8.52e-05 | 115 | 48 | 7 | HP:0012206 | |
| HumanPheno | Abnormal sperm physiology | 8.52e-05 | 115 | 48 | 7 | HP:0034809 | |
| MousePheno | abnormal sperm number | DNHD1 SETX DNAH10 PRAMEF20 PRAMEF15 DRC1 PRAMEF4 CCIN FANCD2 CHTF18 MDC1 ATM CFAP61 CAPZA3 HSF2 PRAMEF27 EPB41L2 PRAMEF11 | 2.82e-06 | 624 | 114 | 18 | MP:0002673 |
| MousePheno | decreased male germ cell number | DNHD1 SETX DNAH10 PRAMEF20 PRAMEF15 DRC1 PRAMEF4 CCIN FANCD2 CHTF18 MDC1 ATM CFAP61 CAPZA3 HSF2 PRAMEF27 EPB41L2 PRAMEF11 | 4.02e-06 | 640 | 114 | 18 | MP:0004901 |
| MousePheno | abnormal gametogenesis | ADCY10 DNHD1 SETX NLRP7 DNAH10 CAPN2 PRAMEF20 PRAMEF15 DRC1 PRAMEF4 ADCY3 CCIN ELMO1 FANCD2 CHTF18 MDC1 ATM CFAP61 CAPZA3 HSF2 NLRP4 PRAMEF27 EPB41L2 PRAMEF11 | 4.39e-06 | 1070 | 114 | 24 | MP:0001929 |
| MousePheno | abnormal germ cell morphology | ADCY10 DNHD1 SETX NLRP7 DNAH10 PRAMEF20 PRAMEF15 DRC1 PRAMEF4 CCIN ELMO1 FANCD2 CHTF18 MDC1 ATM CFAP61 CAPZA3 HSF2 NLRP4 PRAMEF27 EPB41L2 PRAMEF11 | 6.70e-06 | 946 | 114 | 22 | MP:0002208 |
| MousePheno | abnormal foam cell morphology | ADCY10 DNHD1 SETX NLRP7 DNAH10 PRAMEF20 PRAMEF15 DRC1 PRAMEF4 CCIN ELMO1 FANCD2 CHTF18 MDC1 ATM CFAP61 CAPZA3 HSF2 NLRP4 PRAMEF27 EPB41L2 PRAMEF11 | 7.66e-06 | 954 | 114 | 22 | MP:0009840 |
| MousePheno | decreased germ cell number | DNHD1 SETX DNAH10 PRAMEF20 PRAMEF15 DRC1 PRAMEF4 CCIN FANCD2 CHTF18 MDC1 ATM CFAP61 CAPZA3 HSF2 PRAMEF27 EPB41L2 PRAMEF11 | 1.07e-05 | 687 | 114 | 18 | MP:0002209 |
| MousePheno | abnormal spermatogenesis | ADCY10 DNHD1 SETX DNAH10 PRAMEF20 PRAMEF15 DRC1 PRAMEF4 ADCY3 CCIN ELMO1 FANCD2 CHTF18 MDC1 ATM CFAP61 CAPZA3 HSF2 PRAMEF27 EPB41L2 PRAMEF11 | 1.26e-05 | 910 | 114 | 21 | MP:0001156 |
| MousePheno | abnormal gametes | ADCY10 DNHD1 SETX DNAH10 PRAMEF20 PRAMEF15 DRC1 PRAMEF4 CCIN FANCD2 CHTF18 MDC1 ATM CFAP61 CAPZA3 HSF2 PRAMEF27 EPB41L2 PRAMEF11 | 1.80e-05 | 785 | 114 | 19 | MP:0001124 |
| MousePheno | abnormal male germ cell morphology | ADCY10 DNHD1 SETX DNAH10 PRAMEF20 PRAMEF15 DRC1 PRAMEF4 CCIN ELMO1 FANCD2 CHTF18 MDC1 ATM CFAP61 CAPZA3 HSF2 PRAMEF27 EPB41L2 PRAMEF11 | 1.85e-05 | 859 | 114 | 20 | MP:0006362 |
| MousePheno | abnormal male germ cell apoptosis | SETX PRAMEF20 PRAMEF15 PRAMEF4 CCIN ELMO1 CHTF18 HSF2 PRAMEF27 PRAMEF11 | 2.28e-05 | 236 | 114 | 10 | MP:0008280 |
| MousePheno | abnormal cell motility | ADCY10 DNHD1 DNAH10 MYO9B NCKIPSD RAPGEF1 DRC1 GIT2 S1PR1 ADCY3 CCIN DNAH1 DNAAF5 GLG1 SYNE2 TLR4 HHIPL1 PLCG2 CFAP61 CAPZA3 | 2.84e-05 | 885 | 114 | 20 | MP:0020846 |
| MousePheno | abnormal male germ cell physiology | SETX PRAMEF20 PRAMEF15 PRAMEF4 CCIN ELMO1 CHTF18 HSF2 PRAMEF27 PRAMEF11 | 3.03e-05 | 244 | 114 | 10 | MP:0020362 |
| MousePheno | abnormal spermatogonia proliferation | 3.85e-05 | 47 | 114 | 5 | MP:0002685 | |
| MousePheno | enlarged urinary bladder | 4.47e-05 | 116 | 114 | 7 | MP:0011874 | |
| MousePheno | abnormal germ cell physiology | SETX PRAMEF20 PRAMEF15 PRAMEF4 CCIN ELMO1 CHTF18 HSF2 PRAMEF27 PRAMEF11 | 6.49e-05 | 267 | 114 | 10 | MP:0020363 |
| MousePheno | abnormal male reproductive system physiology | ADCY10 DNHD1 SETX DNAH10 PRAMEF20 PRAMEF15 DRC1 PRAMEF4 CDC14B ADCY3 CCIN ELMO1 DNAH1 DNAAF5 CHTF18 MDC1 CHSY3 ATM CFAP61 CAPZA3 HSF2 PRAMEF27 EPB41L2 PRAMEF11 | 1.51e-04 | 1329 | 114 | 24 | MP:0003698 |
| MousePheno | increased male germ cell apoptosis | SETX PRAMEF20 PRAMEF15 PRAMEF4 CCIN CHTF18 PRAMEF27 PRAMEF11 | 1.56e-04 | 189 | 114 | 8 | MP:0014052 |
| MousePheno | male infertility | ADCY10 DNHD1 SETX DNAH10 PRAMEF20 PRAMEF15 DRC1 PRAMEF4 CCIN DNAH1 DNAAF5 MDC1 CHSY3 ATM CFAP61 CAPZA3 PRAMEF27 EPB41L2 PRAMEF11 | 2.13e-04 | 944 | 114 | 19 | MP:0001925 |
| MousePheno | oligozoospermia | DNHD1 DNAH10 DRC1 CCIN FANCD2 CHTF18 MDC1 CFAP61 CAPZA3 HSF2 EPB41L2 | 2.98e-04 | 384 | 114 | 11 | MP:0002687 |
| MousePheno | abnormal jejunum morphology | 3.37e-04 | 41 | 114 | 4 | MP:0004002 | |
| MousePheno | abnormal intracellular organelle physiology | ERCC4 SETX CENPE USP24 SPG11 CDC14B EHHADH MDC1 EIF4E PTCD2 CAMKMT ATM NIPBL | 3.91e-04 | 532 | 114 | 13 | MP:0014241 |
| Domain | PRAME_family | 2.53e-07 | 19 | 142 | 5 | IPR026271 | |
| Domain | L_dom-like | PRAMEF25 NLRP7 PRAMEF20 PRAMEF15 INSR PRAMEF4 NLRP6 TLR4 DMAC2L NLRP4 PRAMEF27 TBCEL | 7.97e-06 | 328 | 142 | 12 | IPR032675 |
| Domain | ARM-type_fold | CAND1 USP24 HEATR1 TRRAP WDFY4 ELMO1 RYR3 DNAAF5 TTI1 ATM NIPBL KPNB1 | 1.11e-05 | 339 | 142 | 12 | IPR016024 |
| Domain | - | PRAMEF25 NLRP7 PRAMEF20 PRAMEF15 PRAMEF4 NLRP6 TLR4 DMAC2L NLRP4 PRAMEF27 TBCEL | 3.52e-05 | 321 | 142 | 11 | 3.80.10.10 |
| Domain | ARM-like | 4.20e-05 | 270 | 142 | 10 | IPR011989 | |
| Domain | - | 5.13e-05 | 222 | 142 | 9 | 1.25.10.10 | |
| Domain | TPR-like_helical_dom | 7.44e-05 | 233 | 142 | 9 | IPR011990 | |
| Domain | HEAT | 7.85e-05 | 58 | 142 | 5 | IPR000357 | |
| Domain | Dynein_HC_stalk | 1.47e-04 | 14 | 142 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.47e-04 | 14 | 142 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.47e-04 | 14 | 142 | 3 | PF08393 | |
| Domain | MT | 1.47e-04 | 14 | 142 | 3 | PF12777 | |
| Domain | EF-hand_1 | 1.64e-04 | 152 | 142 | 7 | PF00036 | |
| Domain | DHC_fam | 1.83e-04 | 15 | 142 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.83e-04 | 15 | 142 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.83e-04 | 15 | 142 | 3 | IPR004273 | |
| Domain | - | 1.88e-04 | 207 | 142 | 8 | 1.25.40.10 | |
| Domain | HEAT_REPEAT | 1.93e-04 | 70 | 142 | 5 | PS50077 | |
| Domain | PH | 2.81e-04 | 278 | 142 | 9 | SM00233 | |
| Domain | PH_DOMAIN | 2.88e-04 | 279 | 142 | 9 | PS50003 | |
| Domain | PH_domain | 2.96e-04 | 280 | 142 | 9 | IPR001849 | |
| Domain | - | 3.23e-04 | 18 | 142 | 3 | 3.30.70.1230 | |
| Domain | Nucleotide_cyclase | 3.23e-04 | 18 | 142 | 3 | IPR029787 | |
| Domain | PH | 3.71e-04 | 229 | 142 | 8 | PF00169 | |
| Domain | Guanylate_cyc | 3.81e-04 | 19 | 142 | 3 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 3.81e-04 | 19 | 142 | 3 | PS50125 | |
| Domain | A/G_cyclase | 3.81e-04 | 19 | 142 | 3 | IPR001054 | |
| Domain | GUANYLATE_CYCLASE_1 | 3.81e-04 | 19 | 142 | 3 | PS00452 | |
| Domain | CYCc | 3.81e-04 | 19 | 142 | 3 | SM00044 | |
| Domain | PH_dom-like | CDC42BPA WDFY4 ELMO1 ITK FGD4 ITSN2 DAPP1 NGEF PLCD1 PLCG2 EPB41L2 | 4.20e-04 | 426 | 142 | 11 | IPR011993 |
| Domain | HEAT | 4.81e-04 | 48 | 142 | 4 | PF02985 | |
| Domain | DAPIN | 5.96e-04 | 22 | 142 | 3 | PS50824 | |
| Domain | PYRIN | 5.96e-04 | 22 | 142 | 3 | SM01289 | |
| Domain | PYRIN | 5.96e-04 | 22 | 142 | 3 | PF02758 | |
| Domain | DAPIN | 5.96e-04 | 22 | 142 | 3 | IPR004020 | |
| Domain | NACHT | 6.82e-04 | 23 | 142 | 3 | PS50837 | |
| Domain | NACHT_NTPase | 6.82e-04 | 23 | 142 | 3 | IPR007111 | |
| Domain | Keratin_2_head | 7.75e-04 | 24 | 142 | 3 | IPR032444 | |
| Domain | Keratin_2_head | 7.75e-04 | 24 | 142 | 3 | PF16208 | |
| Domain | - | CDC42BPA ELMO1 ITK FGD4 ITSN2 DAPP1 NGEF PLCD1 PLCG2 EPB41L2 | 8.26e-04 | 391 | 142 | 10 | 2.30.29.30 |
| Domain | FAT | 8.44e-04 | 6 | 142 | 2 | PS51189 | |
| Domain | FATC | 8.44e-04 | 6 | 142 | 2 | PS51190 | |
| Domain | FAT | 8.44e-04 | 6 | 142 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 8.44e-04 | 6 | 142 | 2 | IPR003151 | |
| Domain | FATC_dom | 8.44e-04 | 6 | 142 | 2 | IPR003152 | |
| Domain | PIK_FAT | 8.44e-04 | 6 | 142 | 2 | IPR014009 | |
| Domain | FATC | 8.44e-04 | 6 | 142 | 2 | SM01343 | |
| Domain | Keratin_II | 9.84e-04 | 26 | 142 | 3 | IPR003054 | |
| Domain | Intermediate_filament_CS | 1.35e-03 | 63 | 142 | 4 | IPR018039 | |
| Domain | SH3_1 | 1.60e-03 | 164 | 142 | 6 | PF00018 | |
| Domain | EF-hand-dom_pair | 1.60e-03 | 287 | 142 | 8 | IPR011992 | |
| Domain | EF_HAND_2 | 1.96e-03 | 231 | 142 | 7 | PS50222 | |
| Domain | RuvA_2-like | 2.00e-03 | 9 | 142 | 2 | IPR010994 | |
| Domain | EF_hand_dom | 2.01e-03 | 232 | 142 | 7 | IPR002048 | |
| Domain | Filament | 2.10e-03 | 71 | 142 | 4 | SM01391 | |
| Domain | IF | 2.21e-03 | 72 | 142 | 4 | PS00226 | |
| Domain | Filament | 2.32e-03 | 73 | 142 | 4 | PF00038 | |
| Domain | IF | 2.69e-03 | 76 | 142 | 4 | IPR001664 | |
| Domain | C2 | 3.28e-03 | 131 | 142 | 5 | PF00168 | |
| Domain | calpain_III | 3.60e-03 | 12 | 142 | 2 | SM00720 | |
| Domain | C2_III | 3.60e-03 | 12 | 142 | 2 | IPR033883 | |
| Domain | Calpain_III | 3.60e-03 | 12 | 142 | 2 | IPR022683 | |
| Domain | - | 3.86e-03 | 261 | 142 | 7 | 1.10.238.10 | |
| Domain | C2 | 3.97e-03 | 137 | 142 | 5 | SM00239 | |
| Domain | Calpain_III | 4.24e-03 | 13 | 142 | 2 | PF01067 | |
| Domain | Calpain_domain_III | 4.24e-03 | 13 | 142 | 2 | IPR022682 | |
| Domain | C2 | 4.62e-03 | 142 | 142 | 5 | PS50004 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.92e-03 | 14 | 142 | 2 | IPR024317 | |
| Domain | ATPase_dyneun-rel_AAA | 4.92e-03 | 14 | 142 | 2 | IPR011704 | |
| Domain | Calpain_cysteine_protease | 4.92e-03 | 14 | 142 | 2 | IPR022684 | |
| Domain | AAA_8 | 4.92e-03 | 14 | 142 | 2 | PF12780 | |
| Domain | AAA_5 | 4.92e-03 | 14 | 142 | 2 | PF07728 | |
| Domain | - | 5.49e-03 | 148 | 142 | 5 | 2.60.40.150 | |
| Domain | - | 5.54e-03 | 93 | 142 | 4 | 1.10.533.10 | |
| Domain | EF-hand_like | 5.65e-03 | 15 | 142 | 2 | PF09279 | |
| Domain | Peptidase_C2 | 5.65e-03 | 15 | 142 | 2 | PF00648 | |
| Domain | PI-PLC-Y | 5.65e-03 | 15 | 142 | 2 | PF00387 | |
| Domain | PLCYc | 5.65e-03 | 15 | 142 | 2 | SM00149 | |
| Domain | Spectrin_alpha_SH3 | 5.65e-03 | 15 | 142 | 2 | IPR013315 | |
| Domain | CysPc | 5.65e-03 | 15 | 142 | 2 | SM00230 | |
| Domain | Peptidase_C2_calpain_cat | 5.65e-03 | 15 | 142 | 2 | IPR001300 | |
| Domain | PLipase_C_Pinositol-sp_Y | 5.65e-03 | 15 | 142 | 2 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 5.65e-03 | 15 | 142 | 2 | PS50008 | |
| Domain | CALPAIN_CAT | 5.65e-03 | 15 | 142 | 2 | PS50203 | |
| Domain | PI-PLC_fam | 5.65e-03 | 15 | 142 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 5.65e-03 | 15 | 142 | 2 | IPR015359 | |
| Domain | SH3 | 6.21e-03 | 216 | 142 | 6 | SM00326 | |
| Domain | SH3 | 6.21e-03 | 216 | 142 | 6 | PS50002 | |
| Domain | - | 6.42e-03 | 16 | 142 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 6.42e-03 | 16 | 142 | 2 | SM00146 | |
| Domain | SH3_domain | 6.78e-03 | 220 | 142 | 6 | IPR001452 | |
| Domain | DEATH-like_dom | 6.90e-03 | 99 | 142 | 4 | IPR011029 | |
| Domain | EFh | 7.20e-03 | 158 | 142 | 5 | SM00054 | |
| Domain | A/G_cyclase_CS | 7.24e-03 | 17 | 142 | 2 | IPR018297 | |
| Domain | HEAT_type_2 | 7.24e-03 | 17 | 142 | 2 | IPR021133 | |
| Domain | SH2 | 7.40e-03 | 101 | 142 | 4 | PF00017 | |
| Pathway | WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 2.25e-05 | 8 | 106 | 3 | M42528 | |
| Pubmed | 2.19e-11 | 28 | 146 | 7 | 25089626 | ||
| Pubmed | NRDE2 ERCC4 SETX PRAMEF20 PRAMEF15 HEATR1 PRAMEF4 GPATCH8 WDFY4 NT5DC1 ADCY3 PPP6C GLG1 TLR4 TSTD2 ACCSL CPSF2 BAIAP3 NLRP4 MFSD1 PRAMEF11 | 5.87e-09 | 1084 | 146 | 21 | 11544199 | |
| Pubmed | SETX CAND1 CDC42BPA CECR2 AMBRA1 SPG11 ADCY9 USP38 SUPT6H MDC1 WDR90 HHIPL1 CPSF2 SYT13 SMG6 | 7.58e-09 | 529 | 146 | 15 | 14621295 | |
| Pubmed | 1.79e-08 | 20 | 146 | 5 | 26694250 | ||
| Pubmed | 3.03e-08 | 22 | 146 | 5 | 31729367 | ||
| Pubmed | 6.04e-08 | 25 | 146 | 5 | 37451217 | ||
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 29357356 | ||
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 7543104 | ||
| Pubmed | Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice. | 1.59e-07 | 30 | 146 | 5 | 38786026 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UTP6 KRT6B SETX CAND1 ERH MYO6 MYO9B CAPN2 AMBRA1 HEATR1 TRRAP NT5DC1 MTPAP CDC45 PPP6C CHTF18 MDC1 PLCG2 NIPBL EPB41L2 KPNB1 | 2.49e-07 | 1353 | 146 | 21 | 29467282 |
| Pubmed | NRDE2 SETX CAND1 CDC42BPA GEMIN2 HEATR1 GPATCH8 TRRAP MTPAP CCNH FGD4 GLG1 SUPT6H RBMX2 MDC1 EIF4E ITSN2 CPSF2 ZNF598 NIPBL EPB41L2 SMG6 | 3.17e-07 | 1497 | 146 | 22 | 31527615 | |
| Pubmed | 3.57e-07 | 35 | 146 | 5 | 19389355 | ||
| Pubmed | Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse. | 6.80e-07 | 17 | 146 | 4 | 23565261 | |
| Pubmed | 6.80e-07 | 17 | 146 | 4 | 37781892 | ||
| Pubmed | 7.20e-07 | 5 | 146 | 3 | 20301457 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KRT6A KRT6B GEMIN2 PRAMEF20 PRAMEF15 PRAMEF4 TUBB2A CCIN CDC45 KRT6C IFT88 PRAMEF11 KPNB1 | 8.32e-07 | 564 | 146 | 13 | 21565611 |
| Pubmed | 8.71e-07 | 18 | 146 | 4 | 23894331 | ||
| Pubmed | Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation. | 8.71e-07 | 18 | 146 | 4 | 39181896 | |
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 8.71e-07 | 18 | 146 | 4 | 12890732 | |
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 8.71e-07 | 18 | 146 | 4 | 29731491 | |
| Pubmed | 8.71e-07 | 18 | 146 | 4 | 14675769 | ||
| Pubmed | 9.69e-07 | 179 | 146 | 8 | 19074885 | ||
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 1.10e-06 | 19 | 146 | 4 | 28604677 | |
| Pubmed | 1.37e-06 | 20 | 146 | 4 | 16580637 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 1.37e-06 | 20 | 146 | 4 | 21425410 | |
| Pubmed | MDC1 is required for the intra-S-phase DNA damage checkpoint. | 1.44e-06 | 6 | 146 | 3 | 12607003 | |
| Pubmed | 1.44e-06 | 6 | 146 | 3 | 12387869 | ||
| Pubmed | 2.48e-06 | 23 | 146 | 4 | 19480014 | ||
| Pubmed | KRT6A KRT6B NLRP7 SLC44A2 SPG11 HEATR1 CFAP210 CCNH RINT1 KRT6C IFT88 SNX25 RBMX2 PAEP SYNE2 ITSN2 ATM USPL1 NIPBL KPNB1 | 2.77e-06 | 1442 | 146 | 20 | 35575683 | |
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | 3.52e-06 | 25 | 146 | 4 | 12620990 | |
| Pubmed | 4.00e-06 | 8 | 146 | 3 | 12019269 | ||
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | 4.15e-06 | 26 | 146 | 4 | 18500982 | |
| Pubmed | 5.08e-06 | 59 | 146 | 5 | 11279525 | ||
| Pubmed | CAND1 ERH MED29 CAPN2 GPATCH8 TRRAP NT5DC1 CDC45 FANCD2 CCNH SUPT6H CHTF18 MDC1 ATM CPSF2 NIPBL | 6.11e-06 | 1014 | 146 | 16 | 32416067 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | UTP6 KRT6A CAND1 GEMIN2 MYO9B INSR HEATR1 TRRAP KRT6C SUPT6H MDC1 SYNE2 CPSF2 NIPBL EPB41L2 KPNB1 | 6.91e-06 | 1024 | 146 | 16 | 24711643 |
| Pubmed | LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance. | 9.78e-06 | 32 | 146 | 4 | 37889087 | |
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 1.17e-05 | 11 | 146 | 3 | 20427287 | |
| Pubmed | 1.17e-05 | 11 | 146 | 3 | 12607005 | ||
| Pubmed | CAPN9 FBXW10B FBXW10 CDC42BPA DNAH10 CAPN2 INSR USP24 CPD TUBB2A SEMA4G ITK PLK3 | 1.36e-05 | 730 | 146 | 13 | 34857952 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 24509855 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 10550543 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 10550545 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 36543851 | ||
| Pubmed | Signaling pathways for modulation of mouse sperm motility by adenosine and catecholamine agonists. | 1.75e-05 | 2 | 146 | 2 | 16291925 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 9790766 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 11489919 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 10953016 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 6207530 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 16115628 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 11118885 | ||
| Pubmed | NLRP6 deficiency expands a novel CD103+ B cell population that confers immune tolerance in NOD mice. | 1.75e-05 | 2 | 146 | 2 | 36911699 | |
| Pubmed | FBXW10 promotes hepatocarcinogenesis in male patients and mice. | 1.75e-05 | 2 | 146 | 2 | 31400758 | |
| Pubmed | Autophosphorylation at serine 1981 stabilizes ATM at DNA damage sites. | 1.75e-05 | 2 | 146 | 2 | 20026654 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 23662636 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 37450367 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 10866680 | ||
| Pubmed | Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. | 1.75e-05 | 2 | 146 | 2 | 12086603 | |
| Pubmed | Cytokeratins mediate epithelial innate defense through their antimicrobial properties. | 1.75e-05 | 2 | 146 | 2 | 23006328 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | MYO6 PRAMEF20 PRAMEF15 PBDC1 USP24 CDH23 GIT2 PRAMEF4 TRRAP ADCY9 ELMO1 MIGA2 GLDC GLG1 CAMKMT CFAP61 PRAMEF11 | 1.95e-05 | 1242 | 146 | 17 | 30973865 |
| Pubmed | 2.18e-05 | 133 | 146 | 6 | 15144186 | ||
| Pubmed | 2.55e-05 | 14 | 146 | 3 | 20403135 | ||
| Pubmed | Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. | 2.55e-05 | 14 | 146 | 3 | 14993377 | |
| Pubmed | 2.55e-05 | 14 | 146 | 3 | 12563287 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | DNHD1 CAND1 ERH CAPN2 SEMA4G PPP6C SUPT6H MDC1 NUB1 PLCD1 CPSF2 KPNB1 | 2.79e-05 | 670 | 146 | 12 | 22990118 |
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 2.88e-05 | 84 | 146 | 5 | 29563501 | |
| Pubmed | 3.41e-05 | 87 | 146 | 5 | 29991678 | ||
| Pubmed | Unpackaging the genetics of mammalian fertility: strategies to identify the "reproductive genome". | 3.90e-05 | 16 | 146 | 3 | 29878059 | |
| Pubmed | 3.90e-05 | 16 | 146 | 3 | 17567809 | ||
| Pubmed | 4.24e-05 | 46 | 146 | 4 | 17287250 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | UTP6 CAND1 MYO6 CAPN2 USP24 CPD HEATR1 TUBB2A FANCD2 DNAAF5 RINT1 PPP6C ZNF598 KPNB1 | 4.59e-05 | 942 | 146 | 14 | 31073040 |
| Pubmed | ADCY10 CAND1 KBTBD6 MYO6 ICE2 PBDC1 SPG11 TRRAP TUBB2A CDC45 FANCD2 PPP6C IFT88 GLDC EIF4E CPSF2 KPNB1 | 4.81e-05 | 1335 | 146 | 17 | 29229926 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 24221507 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 15601842 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 29587848 | ||
| Pubmed | Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. | 5.24e-05 | 3 | 146 | 2 | 18006705 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 16427009 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 22158869 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 17851587 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 14573483 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 20421415 | ||
| Pubmed | The KBTBD6/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment. | 5.24e-05 | 3 | 146 | 2 | 32572597 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 17170733 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 23525077 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 14695167 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 25605334 | ||
| Pubmed | A role for keratins in supporting mitochondrial organization and function in skin keratinocytes. | 5.24e-05 | 3 | 146 | 2 | 32213122 | |
| Pubmed | Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. | 5.24e-05 | 3 | 146 | 2 | 16943440 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 9021139 | ||
| Pubmed | Knockdown of RNF2 enhances the radiosensitivity of squamous cell carcinoma in lung. | 5.24e-05 | 3 | 146 | 2 | 30673298 | |
| Pubmed | Loss of keratin 6 (K6) proteins reveals a function for intermediate filaments during wound repair. | 5.24e-05 | 3 | 146 | 2 | 14568992 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 10770799 | ||
| Pubmed | Identification of a cloned sequence activated during multi-stage carcinogenesis in mouse skin. | 5.24e-05 | 3 | 146 | 2 | 1713533 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NRDE2 KRT6A SETX CAND1 CDC42BPA CECR2 GPATCH8 TRRAP TUBB2A SUPT6H RBMX2 ATM CPSF2 NIPBL KPNB1 | 5.36e-05 | 1082 | 146 | 15 | 38697112 |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 5.54e-05 | 157 | 146 | 6 | 30686591 | |
| Pubmed | Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening. | 5.91e-05 | 50 | 146 | 4 | 19807924 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | 5.91e-05 | 50 | 146 | 4 | 31806660 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | UTP6 SETX MYO9B HEATR1 CPS1 TRRAP MTPAP KBTBD7 TUBB2A RINT1 CHSY3 CPSF2 ZNF598 | 7.06e-05 | 857 | 146 | 13 | 25609649 |
| Pubmed | 8.61e-05 | 55 | 146 | 4 | 19536092 | ||
| Pubmed | ETAA1 acts at stalled replication forks to maintain genome integrity. | 9.12e-05 | 21 | 146 | 3 | 27723720 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | KRT6A KRT6B CAND1 CAPN2 USP24 CPS1 TUBB2A KRT6C GLG1 SUPT6H CHTF18 MDC1 SYNE2 EIF4E NIPBL EPB41L2 KPNB1 | 9.77e-05 | 1415 | 146 | 17 | 28515276 |
| Interaction | GPR17 interactions | SETX GEMIN2 USP24 SPG11 HEATR1 FANCD2 DNAAF5 RINT1 SLC30A5 MIGA2 TTI1 ATM | 7.43e-07 | 283 | 141 | 12 | int:GPR17 |
| Interaction | COMTD1 interactions | 1.18e-05 | 200 | 141 | 9 | int:COMTD1 | |
| Interaction | PRAMEF5 interactions | 1.83e-05 | 8 | 141 | 3 | int:PRAMEF5 | |
| Cytoband | 1p36.21 | 1.36e-09 | 63 | 146 | 7 | 1p36.21 | |
| GeneFamily | PRAME family | PRAMEF25 PRAMEF9 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11 | 4.10e-11 | 24 | 100 | 7 | 686 |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.92e-05 | 10 | 100 | 3 | 53 | |
| GeneFamily | EF-hand domain containing | 2.14e-04 | 219 | 100 | 7 | 863 | |
| GeneFamily | NLR family | 3.46e-04 | 25 | 100 | 3 | 666 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 3.46e-04 | 25 | 100 | 3 | 994 | |
| GeneFamily | Keratins, type II | 4.36e-04 | 27 | 100 | 3 | 609 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 1.61e-03 | 11 | 100 | 2 | 559 | |
| GeneFamily | SH2 domain containing | 2.39e-03 | 101 | 100 | 4 | 741 | |
| GeneFamily | C2 domain containing|Calpains | 3.03e-03 | 15 | 100 | 2 | 975 | |
| GeneFamily | Ubiquitin specific peptidases | 3.68e-03 | 56 | 100 | 3 | 366 | |
| GeneFamily | Dyneins, axonemal | 3.90e-03 | 17 | 100 | 2 | 536 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 4.87e-03 | 19 | 100 | 2 | 832 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 5.39e-03 | 20 | 100 | 2 | 548 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.84e-03 | 66 | 100 | 3 | 722 | |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | DNAH10 USP24 FBXO36 DRC1 CFAP210 EFHB DNAH1 EFHC2 IFT88 WDR90 PLCG2 CFAP61 BAIAP3 | 1.75e-06 | 459 | 145 | 13 | M39136 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED | 1.61e-05 | 57 | 145 | 5 | MM1262 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | SETX CDC42BPA CENPE MYO6 ICE2 SPG11 CCNH RINT1 SLC30A5 SYNE2 ITSN2 ETAA1 ATM NIPBL | 1.77e-05 | 656 | 145 | 14 | M18979 |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP | 2.07e-05 | 340 | 145 | 10 | M2012 | |
| Coexpression | KINNEY_DNMT1_METHYLATION_TARGETS | 3.66e-05 | 34 | 145 | 4 | MM955 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | SETX ICE2 CECR2 HEATR1 GPATCH8 CDC45 FANCD2 GLDC SNX25 RBMX2 MDC1 CAMKMT PCOLCE2 ATM PLCG2 CFAP61 HSF2 NLRP4 | 5.69e-06 | 820 | 137 | 18 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.73e-07 | 195 | 146 | 8 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.82e-07 | 154 | 146 | 7 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.82e-07 | 154 | 146 | 7 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.16e-07 | 155 | 146 | 7 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.16e-07 | 155 | 146 | 7 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.22e-06 | 180 | 146 | 7 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.56e-06 | 184 | 146 | 7 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.56e-06 | 184 | 146 | 7 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 2.56e-06 | 184 | 146 | 7 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.56e-06 | 184 | 146 | 7 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.56e-06 | 184 | 146 | 7 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.66e-06 | 185 | 146 | 7 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.66e-06 | 185 | 146 | 7 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.96e-06 | 188 | 146 | 7 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.06e-06 | 189 | 146 | 7 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-06 | 194 | 146 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.76e-06 | 195 | 146 | 7 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 3.76e-06 | 195 | 146 | 7 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.44e-06 | 200 | 146 | 7 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.44e-06 | 200 | 146 | 7 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.44e-06 | 200 | 146 | 7 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.44e-06 | 200 | 146 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.44e-06 | 200 | 146 | 7 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-05 | 151 | 146 | 6 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-05 | 151 | 146 | 6 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.30e-05 | 173 | 146 | 6 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_ciliated|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.46e-05 | 175 | 146 | 6 | b1369d2b74f461e6822d0c33e9b50fe0dfbceb54 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.46e-05 | 175 | 146 | 6 | c82ec6deb6ccdd991a69a62b6d62d5b14c803d7a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.62e-05 | 177 | 146 | 6 | 37d1abe1a9d8f2b8f4d146bbf1db94104eab6593 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.70e-05 | 178 | 146 | 6 | 9e1f2596fcea5b79cc50b58d83706bb8605e224f | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.70e-05 | 178 | 146 | 6 | aa659bd283c4dfbe292cd8698bbf6b1999ca3314 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-05 | 178 | 146 | 6 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.70e-05 | 178 | 146 | 6 | bf1d273802a4f42e52ea1bd2a0cae2039559c093 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 180 | 146 | 6 | 9db9899ca42455310e9b63df523fe6c4780abfb7 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.06e-05 | 182 | 146 | 6 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 3.06e-05 | 182 | 146 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 3.25e-05 | 184 | 146 | 6 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 3.25e-05 | 184 | 146 | 6 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.25e-05 | 184 | 146 | 6 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.35e-05 | 185 | 146 | 6 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 3.35e-05 | 185 | 146 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.46e-05 | 186 | 146 | 6 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.56e-05 | 187 | 146 | 6 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 3.67e-05 | 188 | 146 | 6 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.67e-05 | 188 | 146 | 6 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | CTRL-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 3.78e-05 | 189 | 146 | 6 | 14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 3.78e-05 | 189 | 146 | 6 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 3.78e-05 | 189 | 146 | 6 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 4.01e-05 | 191 | 146 | 6 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-T_follicular_helper_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.13e-05 | 192 | 146 | 6 | 3e2a0f332e7f9833ba88f3c809cee78b65090401 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.25e-05 | 193 | 146 | 6 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.25e-05 | 193 | 146 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 193 | 146 | 6 | a7002acf3be76b2cc6fc9364176f6b0d3bd27d9c | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 4.50e-05 | 195 | 146 | 6 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.63e-05 | 196 | 146 | 6 | fc67d8aad1ec4d7f98ffe44fb103e230b9b42c35 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 4.63e-05 | 196 | 146 | 6 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.76e-05 | 197 | 146 | 6 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.76e-05 | 197 | 146 | 6 | 0f489d26e4013d1b5a90559856ed2de32a0bb772 | |
| ToppCell | distal-3-Epithelial-Proximal_Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.76e-05 | 197 | 146 | 6 | 15b4d1203943ce90a7083178d4a4284d9b323071 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.90e-05 | 198 | 146 | 6 | f31790442ef142f1c0c49bf3daf2d0efb193d2c9 | |
| ToppCell | COVID-19-Myeloid|COVID-19 / group, cell type (main and fine annotations) | 4.90e-05 | 198 | 146 | 6 | 33f0a919188a67d2a876b52c61a1cec2c9747969 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 5.03e-05 | 199 | 146 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.03e-05 | 199 | 146 | 6 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.03e-05 | 199 | 146 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.03e-05 | 199 | 146 | 6 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.18e-05 | 200 | 146 | 6 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 5.18e-05 | 200 | 146 | 6 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.18e-05 | 200 | 146 | 6 | af6a551f83808c1c839df7ba7b1702ca28ea6e1b | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 5.18e-05 | 200 | 146 | 6 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.18e-05 | 200 | 146 | 6 | 73ac1cf40ddd764be1100cbfaaa29563665457d8 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.18e-05 | 200 | 146 | 6 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.18e-05 | 200 | 146 | 6 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.18e-05 | 200 | 146 | 6 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 8.90e-05 | 137 | 146 | 5 | b553958e7e6dcd887d860e34d3983cbb85cefaa6 | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma|TCGA-Uterus / Sample_Type by Project: Shred V9 | 1.41e-04 | 151 | 146 | 5 | 2810bfa01bd3016aeba29735eb4a9284792e8aac | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.49e-04 | 153 | 146 | 5 | b37a1ecad389d2848b8ca4d287823e8048207420 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 154 | 146 | 5 | cd99428c282d566b5dbd31fd5a0371b7ffe9ffa2 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.64e-04 | 156 | 146 | 5 | c380142e49b1e4ecacbf37587aafa57f8562b6ad | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.64e-04 | 156 | 146 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 156 | 146 | 5 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.76e-04 | 85 | 146 | 4 | 642755ed2b562dd5e599a04a2b9730e8d29aefe8 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.76e-04 | 85 | 146 | 4 | 2429bacccd103e5b2414264b4aff3103ed9d7cec | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 160 | 146 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 160 | 146 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-04 | 162 | 146 | 5 | 7d43d59531cbefe3ac94953b7faf7156b2a31441 | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 2.31e-04 | 168 | 146 | 5 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.31e-04 | 168 | 146 | 5 | 8f0c4dfad9f6fed9dcc31795abfe77758ceb46a1 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-04 | 169 | 146 | 5 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | COVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters | 2.37e-04 | 169 | 146 | 5 | 6abfdc8b437f19c03b408bedc245059d28c6ba6a | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-04 | 169 | 146 | 5 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Monophasic_Synovial_Sarcoma-5|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.48e-04 | 93 | 146 | 4 | 3e05ea0f8f4a7cdb78a596f47d563dc3c94d4d8e | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.57e-04 | 172 | 146 | 5 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.64e-04 | 173 | 146 | 5 | 4968712af1cca8c932abd3323631d7dcaffd4a66 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.64e-04 | 173 | 146 | 5 | 79d11f94a8f6a420c18c2fef0da77e9af3204765 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-04 | 174 | 146 | 5 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-04 | 177 | 146 | 5 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.01e-04 | 178 | 146 | 5 | 2c581a338bf33dbd2be9abe87d0a84f97dfb546f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.01e-04 | 178 | 146 | 5 | be4976bbfd9ebbc568155ede99a07670c43aa372 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-04 | 178 | 146 | 5 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.01e-04 | 178 | 146 | 5 | 5caeffb70cbb868586bd260b44ccd3751bbfa615 | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; PC3; HT_HG-U133A | 4.79e-07 | 195 | 144 | 10 | 7377_UP | |
| Drug | NSC339663 | 4.51e-06 | 250 | 144 | 10 | CID000003892 | |
| Drug | Nimesulide [51803-78-2]; Down 200; 13uM; PC3; HT_HG-U133A | 4.52e-06 | 196 | 144 | 9 | 2112_DN | |
| Drug | Fluorometholone [426-13-1]; Down 200; 10.6uM; PC3; HT_HG-U133A | 4.71e-06 | 197 | 144 | 9 | 5771_DN | |
| Drug | SC-791 | 4.89e-06 | 6 | 144 | 3 | CID010291510 | |
| Drug | Bhg-(2-1)fuc | 1.75e-05 | 25 | 144 | 4 | CID005287784 | |
| Drug | eye gene | ADCY10 KRT6A KRT6B MYO6 MYO9B ADCY3 ADCY9 KRT6C EIF4E PLCD1 PLCG2 | 2.39e-05 | 369 | 144 | 11 | CID000004782 |
| Drug | carbamazepine; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.37e-05 | 194 | 144 | 8 | 952_DN | |
| Drug | NS-398; Up 200; 10uM; MCF7; HT_HG-U133A | 3.62e-05 | 196 | 144 | 8 | 6911_UP | |
| Drug | Lysergol [602-85-7]; Down 200; 15.8uM; PC3; HT_HG-U133A | 3.76e-05 | 197 | 144 | 8 | 6621_DN | |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 3.89e-05 | 198 | 144 | 8 | 1689_UP | |
| Drug | Metampicillin sodium salt [6489-61-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 3.89e-05 | 198 | 144 | 8 | 2123_DN | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 3.89e-05 | 198 | 144 | 8 | 5325_DN | |
| Disease | Kartagener Syndrome | 1.85e-05 | 35 | 133 | 4 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 1.85e-05 | 35 | 133 | 4 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 1.85e-05 | 35 | 133 | 4 | C4317124 | |
| Disease | Primary ciliary dyskinesia | 2.08e-05 | 36 | 133 | 4 | cv:C0008780 | |
| Disease | Gastric Adenocarcinoma | 5.09e-05 | 45 | 133 | 4 | C0278701 | |
| Disease | Primary Ciliary Dyskinesia | 6.05e-05 | 47 | 133 | 4 | C4551720 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 7.14e-05 | 49 | 133 | 4 | EFO_0006954, EFO_1001069 | |
| Disease | platelet measurement | 9.53e-05 | 315 | 133 | 8 | EFO_0005036 | |
| Disease | Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) measurement | 1.20e-04 | 4 | 133 | 2 | EFO_0022116 | |
| Disease | Pachyonychia congenita syndrome | 1.20e-04 | 4 | 133 | 2 | cv:C0265334 | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 1.20e-04 | 4 | 133 | 2 | C1706595 | |
| Disease | pachyonychia congenita (is_implicated_in) | 1.20e-04 | 4 | 133 | 2 | DOID:0050449 (is_implicated_in) | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 1.20e-04 | 4 | 133 | 2 | C1721007 | |
| Disease | melanoma | 1.38e-04 | 248 | 133 | 7 | C0025202 | |
| Disease | Pachyonychia Congenita | 2.00e-04 | 5 | 133 | 2 | C0265334 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.02e-04 | 264 | 133 | 7 | EFO_0008317, EFO_0020944 | |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 2.16e-04 | 26 | 133 | 3 | OBA_2045191 | |
| Disease | Congenital muscular dystrophy (disorder) | 2.99e-04 | 6 | 133 | 2 | C0699743 | |
| Disease | 3-methylglutaconate measurement | 2.99e-04 | 6 | 133 | 2 | EFO_0800047 | |
| Disease | arachidonic acid measurement, fatty acid measurement | 2.99e-04 | 6 | 133 | 2 | EFO_0005110, EFO_0006808 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.65e-04 | 291 | 133 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | hexanoylglycine measurement | 4.17e-04 | 7 | 133 | 2 | EFO_0800233 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 5.25e-04 | 222 | 133 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | Fanconi anemia (implicated_via_orthology) | 5.55e-04 | 8 | 133 | 2 | DOID:13636 (implicated_via_orthology) | |
| Disease | 1-palmitoyl-2-oleoyl-GPI (16:0/18:1) measurement | 7.11e-04 | 9 | 133 | 2 | EFO_0800439 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 7.79e-04 | 91 | 133 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | Cutaneous Melanoma | 8.42e-04 | 41 | 133 | 3 | C0151779 | |
| Disease | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) measurement | 8.86e-04 | 10 | 133 | 2 | EFO_0800608 | |
| Disease | 1-stearoyl-2-oleoyl-GPI (18:0/18:1) measurement | 8.86e-04 | 10 | 133 | 2 | EFO_0800469 | |
| Disease | mean reticulocyte volume | RAPSN ANK1 FNTB MYO9B TRRAP TUBB2A ADCY9 CHTF18 PCOLCE2 ATM EPB41L2 | 1.01e-03 | 799 | 133 | 11 | EFO_0010701 |
| Disease | 1-stearoyl-2-oleoyl-GPE (18:0/18:1) measurement | 1.08e-03 | 11 | 133 | 2 | EFO_0800269 | |
| Disease | 3-methylglutarylcarnitine (2) measurement | 1.08e-03 | 11 | 133 | 2 | EFO_0800074 | |
| Disease | level of Sphingomyelin (d34:0) in blood serum | 1.08e-03 | 11 | 133 | 2 | OBA_2045176 | |
| Disease | Antihypertensive use measurement | 1.31e-03 | 265 | 133 | 6 | EFO_0009927 | |
| Disease | glycerophospholipid measurement | 1.42e-03 | 49 | 133 | 3 | EFO_0007630 | |
| Disease | pallidum volume change measurement | 1.52e-03 | 13 | 133 | 2 | EFO_0021494 | |
| Disease | Diabetic Neuralgia | 1.77e-03 | 14 | 133 | 2 | C0751074 | |
| Disease | Diabetic Neuropathies | 1.77e-03 | 14 | 133 | 2 | C0011882 | |
| Disease | Asymmetric Diabetic Proximal Motor Neuropathy | 1.77e-03 | 14 | 133 | 2 | C0271674 | |
| Disease | Symmetric Diabetic Proximal Motor Neuropathy | 1.77e-03 | 14 | 133 | 2 | C0271673 | |
| Disease | Diabetic Mononeuropathy | 1.77e-03 | 14 | 133 | 2 | C0271678 | |
| Disease | Diabetic Autonomic Neuropathy | 1.77e-03 | 14 | 133 | 2 | C0271686 | |
| Disease | Diabetic Amyotrophy | 1.77e-03 | 14 | 133 | 2 | C0271685 | |
| Disease | Diabetic Polyneuropathies | 1.77e-03 | 14 | 133 | 2 | C0271680 | |
| Disease | Adenocarcinoma Of Esophagus | 1.77e-03 | 14 | 133 | 2 | C0279628 | |
| Disease | Diabetic Asymmetric Polyneuropathy | 1.77e-03 | 14 | 133 | 2 | C0393835 | |
| Disease | diabetic neuropathy (implicated_via_orthology) | 1.77e-03 | 14 | 133 | 2 | DOID:9743 (implicated_via_orthology) | |
| Disease | Drug habituation | 1.85e-03 | 115 | 133 | 4 | C0013170 | |
| Disease | Drug abuse | 1.85e-03 | 115 | 133 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.85e-03 | 115 | 133 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 1.85e-03 | 115 | 133 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 1.85e-03 | 115 | 133 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.85e-03 | 115 | 133 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.85e-03 | 115 | 133 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.85e-03 | 115 | 133 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.85e-03 | 115 | 133 | 4 | C0029231 | |
| Disease | Substance abuse problem | 1.91e-03 | 116 | 133 | 4 | C0740858 | |
| Disease | phosphatidate measurement | 2.04e-03 | 15 | 133 | 2 | EFO_0020047 | |
| Disease | high density lipoprotein cholesterol measurement, metabolic syndrome | 2.04e-03 | 15 | 133 | 2 | EFO_0000195, EFO_0004612 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.17e-03 | 200 | 133 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 2.17e-03 | 200 | 133 | 5 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 2.32e-03 | 16 | 133 | 2 | C0334634 | |
| Disease | body surface area | 2.61e-03 | 643 | 133 | 9 | EFO_0022196 | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 2.62e-03 | 17 | 133 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | Amyotrophic lateral sclerosis | 2.62e-03 | 17 | 133 | 2 | cv:C0002736 | |
| Disease | eicosapentaenoate EPA; 20:5n3 measurement | 2.62e-03 | 17 | 133 | 2 | EFO_0021049 | |
| Disease | reticulocyte count | ANK1 DNAH10 FNTB MYO9B INSR SLC44A2 ADCY3 NLRP6 SYNE2 PLCG2 BAIAP3 SMG6 | 2.77e-03 | 1045 | 133 | 12 | EFO_0007986 |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 2.94e-03 | 18 | 133 | 2 | OBA_2045155 | |
| Disease | reticulocyte measurement | ANK1 DNAH10 FNTB MYO9B INSR SLC44A2 ADCY3 SYNE2 PCOLCE2 PLCG2 BAIAP3 SMG6 | 2.95e-03 | 1053 | 133 | 12 | EFO_0010700 |
| Disease | apolipoprotein B measurement | 3.19e-03 | 663 | 133 | 9 | EFO_0004615 | |
| Disease | ovarian neoplasm | 3.22e-03 | 134 | 133 | 4 | C0919267 | |
| Disease | lymphocyte percentage of leukocytes | 3.26e-03 | 665 | 133 | 9 | EFO_0007993 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 3.28e-03 | 19 | 133 | 2 | OBA_2045199 | |
| Disease | breast carcinoma (is_marker_for) | 3.33e-03 | 66 | 133 | 3 | DOID:3459 (is_marker_for) | |
| Disease | venous thromboembolism, fibrinogen measurement | 3.47e-03 | 67 | 133 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | Malignant neoplasm of ovary | 3.49e-03 | 137 | 133 | 4 | C1140680 | |
| Disease | glycine measurement | 3.49e-03 | 137 | 133 | 4 | EFO_0009767 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 3.53e-03 | 224 | 133 | 5 | EFO_0004530, EFO_0008317 | |
| Disease | bilirubin measurement | 3.99e-03 | 442 | 133 | 7 | EFO_0004570 | |
| Disease | sex interaction measurement, cerebral amyloid angiopathy | 4.00e-03 | 21 | 133 | 2 | EFO_0006790, EFO_0008343 | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 4.00e-03 | 21 | 133 | 2 | EFO_0004286, EFO_0004792 | |
| Disease | metabolite measurement, diet measurement | 4.09e-03 | 71 | 133 | 3 | EFO_0004725, EFO_0008111 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 4.17e-03 | 144 | 133 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | progranulin measurement | 4.39e-03 | 22 | 133 | 2 | EFO_0004625 | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 4.39e-03 | 22 | 133 | 2 | EFO_0009312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LDYDCQKAELFVTRL | 166 | Q7L8C5 | |
| TFEEERLLYCRFLDN | 496 | Q4AC99 | |
| EFVNAFDDLCLLIRD | 26 | Q96KX2 | |
| QLYERCILLDIEFSD | 621 | Q86US8 | |
| YTELLSDDFTNRCLL | 291 | Q8WVB6 | |
| TERLIADYACALQRD | 81 | Q8IYS0 | |
| QLFCIDEKYEARSLD | 391 | Q8NHU2 | |
| EVLELAFSILYDSNC | 636 | Q92556 | |
| ADDFLNRIALTDAYL | 191 | P51946 | |
| ANCLRYLFLAELFEL | 131 | Q13939 | |
| ESALCYLLQVDEFRF | 16 | Q9P2I0 | |
| YLLQVDEFRFLLDCG | 21 | Q9P2I0 | |
| QDVCEATLFYTELLR | 771 | O94812 | |
| DDVYLDITDRLCFAI | 46 | O60729 | |
| DHLDCVRLLLQYDAE | 316 | P16157 | |
| VRALFLCEEENFLLS | 456 | Q5XX13 | |
| LCEEENFLLSGSYDL | 461 | Q5XX13 | |
| EIQYELTDRLAFYLC | 221 | Q14161 | |
| YQFLEEKDRAALCQL | 386 | Q3MIX3 | |
| ELDRCYELLDLQTAL | 426 | Q96M86 | |
| YASACEFLDIVELLL | 231 | Q9BR61 | |
| IVSCEYDALRDNSLL | 341 | Q5VUY0 | |
| TLLDEKFYCLLNDIF | 586 | Q96PN6 | |
| CDLRRFFLEYDRLQE | 501 | Q9C0C7 | |
| YIEDDCLLRLSQLEN | 136 | Q99766 | |
| FCSVYITLLNELDEA | 1296 | Q9H251 | |
| CDYRLDADDVFDLLK | 121 | Q9BXF3 | |
| LDTLDLLAIYCRNEA | 156 | Q9Y2D1 | |
| LEDADFLLESYLNLA | 76 | Q13702 | |
| FLCYEDQRSTILAVD | 81 | Q9Y388 | |
| DLYQDVLCLTLFDRD | 1626 | Q9NZM3 | |
| DYDLEFGTECLQLAL | 231 | A4D126 | |
| YFRLEQLECLDDAEK | 291 | Q9Y5A7 | |
| VRALFLCEEENFLLS | 456 | O95170 | |
| LCEEENFLLSGSYDL | 461 | O95170 | |
| TLLDTDYDNFLFLCL | 111 | P09466 | |
| LTDEINFLRALYDAE | 291 | P48668 | |
| CRLLCEYILGNDFTD | 226 | Q5TFE4 | |
| RDQELILFADLLCQY | 116 | Q14676 | |
| LLICLVSRYFDQRDL | 261 | O14893 | |
| NLARFCRYLSLDDTD | 141 | Q96JK4 | |
| LTDEINFLRALYDAE | 291 | P02538 | |
| LETLLCLIGESFDDY | 131 | P06730 | |
| TLLDSCLDRLDIFEF | 1091 | Q86VP6 | |
| EDITRYFLCLQLRQD | 306 | O43491 | |
| ERCLYSLINEAFRIL | 621 | Q08426 | |
| RRELILHYFLCDDTI | 246 | Q5JST6 | |
| AKALEDLRANFYCEL | 126 | Q9UKJ3 | |
| LTDEINFLRALYDAE | 291 | P04259 | |
| IVEDFNYGTLLRLDC | 111 | Q9BVG4 | |
| IDDLADLSCLVYRAD | 61 | P84090 | |
| DLLDQVFYCKLLEEA | 226 | Q96M96 | |
| ISYLDLEDIARLCQT | 106 | Q8NEA4 | |
| DTVDYDDACLIVRYL | 1746 | Q6KC79 | |
| CELSLLYAELEVELS | 821 | Q9H7Z3 | |
| AATLEYLDLDDCGII | 351 | P0DUQ1 | |
| AADDFRLKYENELCL | 226 | Q2M2I5 | |
| LICALALAYLDQRAE | 226 | Q9H3U5 | |
| LRTELLGCYSDQDFL | 336 | Q7L4E1 | |
| LSRDDIRSLCDALNY | 706 | Q96MN2 | |
| LEEFYALCDQLELCL | 106 | Q9NX70 | |
| RQAEDSELFELDYCL | 661 | P06213 | |
| LQLEYVREACASFLA | 151 | Q8WVZ9 | |
| RFIDLESDNLCRYDF | 76 | Q9UKZ9 | |
| YSEDIELASLLVFCE | 1171 | P16885 | |
| LFELLCYAESIDDQL | 176 | Q9NVV4 | |
| NECYLLRLDAIFSAL | 521 | Q96MC2 | |
| DDDLLYQACDDIERL | 606 | Q9NY74 | |
| DLALIRFLVEDYDAS | 696 | P51178 | |
| CFENIARLLFQEDLE | 1356 | Q9P2D7 | |
| DCEHRLLELQYFISR | 541 | Q92896 | |
| EALCDAYIILANLDA | 2621 | Q13315 | |
| ECDKLYFEELSLERI | 1026 | P31327 | |
| DCTRISFEYDLRLVL | 266 | O75419 | |
| LTYEKLNRLDEALDC | 526 | Q13099 | |
| NECRKIESLENLYLD | 381 | Q659A1 | |
| RILDLTECSAVQFDY | 206 | Q9UN19 | |
| TELLLALAEFLCLNY | 1001 | O75976 | |
| IECLRFLNEIISDFD | 946 | O60266 | |
| CYRVLNELIGDFDEL | 1081 | O60503 | |
| LRCDDEKEQFLYHLL | 921 | Q6IQ26 | |
| DYLNELRESCLEAYT | 756 | Q14974 | |
| ERDLYLSLEDLFFGC | 141 | P59910 | |
| SLDDKLLDQLFDYCD | 596 | Q8N7U6 | |
| LRQLTDAYECLDASR | 86 | P49356 | |
| TLFLCFLEDLERNDG | 666 | Q8IWA5 | |
| DRLLTFYNLADCIAE | 1931 | Q9H583 | |
| QASENDLYLERLLLC | 486 | Q86Y56 | |
| NDRFEGYCIDLLREL | 456 | Q13002 | |
| LDFDDFLNCLVRLEN | 646 | O14815 | |
| DYEALRNECLEAGTL | 31 | P17655 | |
| EIEDLDLLECYFLEA | 2331 | Q8IVF4 | |
| TCDILFRAEYFLVLA | 286 | P21453 | |
| DDHYECLNRLSLDLE | 2111 | Q02224 | |
| LLYCLYETQEDAFVR | 621 | P59044 | |
| LQLEYVREACASFLA | 151 | Q86V97 | |
| ESYIEDEDSFRNCLL | 101 | Q9BXW9 | |
| VTFFCDLLLLYVDRE | 351 | O15547 | |
| FVRLCYELDLEESAV | 136 | Q8WV60 | |
| LDYLDSIDCSLEDFQ | 361 | Q03933 | |
| ALRRNEEYCLLDSSE | 191 | Q08881 | |
| SVSLLCYNFLREALE | 376 | Q9NYH9 | |
| RFNDLISCIRIDNLY | 596 | Q7Z6B7 | |
| YVENLRLLRACFEET | 591 | Q8WXH0 | |
| EVELLTDFLCFLEIY | 211 | Q17RQ9 | |
| LSDERLCQSEALYAF | 606 | Q9H3E2 | |
| EIYLFLFNDLLVICR | 516 | Q8N5V2 | |
| IDLCLKNRTLDEYFT | 151 | Q5VT98 | |
| AATLEYLDLDDCGII | 351 | A6NGN4 | |
| VDRDDYYDLQEVLLC | 181 | Q7Z333 | |
| SIDNEALYDICFRTL | 201 | Q13885 | |
| FELDIEFERCTYLTI | 636 | Q8WX94 | |
| AATLEYLDLDDCGII | 351 | A3QJZ7 | |
| FSVETLLDILICLYD | 26 | Q5VT25 | |
| RCYLEELLHILTDAD | 411 | Q9NZQ3 | |
| QAELDYCRLTEALVA | 451 | Q0VFZ6 | |
| ADCLFLDQYRASLVD | 231 | Q7Z624 | |
| DTLLLFCDVDLIFRE | 711 | Q70JA7 | |
| LICRACFDELQSEYL | 186 | Q16281 | |
| KEELLNALYCEFINR | 951 | Q7KZ85 | |
| ASELEDFECFLLRLS | 951 | Q96JI7 | |
| AATLEYLDLDDCGII | 351 | O60810 | |
| DADNIYIFLELCSRK | 131 | Q9H4B4 | |
| YRISFQESIFLCEDL | 61 | Q5W0Q7 | |
| SLLVRNLYTSDLCFE | 171 | Q96KV7 | |
| LEASAICRYDLAEIQ | 331 | Q9NTN9 | |
| LLYDDNLFCHLVDEV | 391 | Q6NUQ1 | |
| ETDRKDLVLYCEAFL | 706 | Q13905 | |
| RLCDYVCDLLLEESN | 26 | O00743 | |
| ILDEFAVLCRDLYAF | 3251 | Q15413 | |
| AATLEYLDLDDCGII | 351 | P0DUQ2 | |
| IFLDDECYREASLSI | 576 | Q6ZS81 | |
| AATLEYLDLDDCGII | 351 | O60813 | |
| DDLENCILRFSDLDL | 11 | Q5T7W7 | |
| SQQDCSEYLRFLLDR | 521 | Q8NB14 | |
| NDDILNLARYFECSL | 966 | O60290 | |
| FCDERYLDNDELLKH | 191 | Q86UK7 | |
| YFDLRCQLLDDLTTS | 1511 | Q9UPU5 | |
| LEESDSRQIFYFLCL | 411 | Q8TAD4 | |
| QEVRLRFLSYEDLIC | 91 | A6NK53 | |
| YDCVTFLNLLESLRA | 301 | Q92889 | |
| CNLTIEEFRLAYLDY | 281 | O00206 | |
| AFYLEELDEARECFL | 76 | Q5TAA0 | |
| YTELLNLCEAEDSAL | 1336 | Q9Y4A5 | |
| PDLEELFLCLNDYET | 151 | Q5QJ74 | |
| ELLQELFSELSACLY | 91 | O43156 | |
| YQQLFRELEKDLCEL | 591 | P23378 | |
| SLEYCAELLGLDQDD | 371 | Q9UM54 | |
| ELCFDDELVLQQLRY | 861 | Q13459 |